Recall Record

Plano, TX, United States

Abbott Medical recalls

16 recalls recorded since 2018, most recently on 12 May 2026. 12 are listed as ongoing. Status and classification are as published by the FDA.

Recalls16
Ongoing (FDA)12
Terminated or completed4
Class I (FDA)1

Ongoing Class II Medical devices

Recall started
12 May 2026
Reason
Software malfunction may occur during pacing capture threshold test of pacemaker resulting in programmer not successfully communicating the command to terminate the test.
Distribution
US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY. OUS: Not provided yet
Initiated
Voluntary: Firm initiated
Recall number
Z-2405-2026

Ongoing Class II Medical devices

Recall started
6 October 2025
Reason
There is a potential issue affecting Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generators (IPGs), Model 32400 and Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs), Model 62400 . These devicess may experience a loss of communication with the Clinician Programmer (CP) and/or the Patient Controller (PC).
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0458-2026, Z-0459-2026

Ongoing Class II Medical devices

Recall started
15 February 2025
Reason
Due to a manufacturing issue, leadless pacemakers may have been exposed to higher than normal temperatures which may result in premature battery failure.
Distribution
Worldwide - U.S. Nationwide distribution in the states of FL, SC, and WV and the country of Spain. There were five (5) LSP202V devices distributed within the United States (3 in FL, 1 in SC, 1 in WV) that are impacted by this issue, two (2) of which were implanted, see Attachment A.3 for list of s
Initiated
Voluntary: Firm initiated
Recall number
Z-1557-2025

Ongoing Class II Medical devices

Recall started
21 November 2024
Reason
Due to a programmer software anomaly, during finalizing of the leadless pacemaker system, a specific sequence of programmer actions combined with a loss of telemetry during a small window (<2 seconds) may cause the finalization step to fail. If this occurs, the Programmer displays a loss of telemetry detected window, and there is no pacing.
Distribution
Worldwide - U.S. Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, TN TX, UT, VA, WA, WI, and WV. The countries of Austria, Belgium, Canada, Denmar
Initiated
Voluntary: Firm initiated
Recall number
Z-0753-2025

Ongoing Class II Medical devices

Recall started
17 October 2024
Reason
A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Distribution
New York, Australia, Belgium, Germany, Iran, Israel, Japan, Kazakhstan, Oman, Poland, Romania, Slovakia, Spain, Turkey, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0495-2025, Z-0492-2025, Z-0491-2025, Z-0494-2025, Z-0493-2025

Ongoing Class III Medical devices

Recall started
1 October 2024
Reason
Due to heart transmitter not being able to upgrade to the current software version in the field after experiencing a power interruption during a prior over-the-wire software download.
Distribution
Worldwide - U.S. Nationwide distribution in the states of ALABAMA, ALASKA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, ILLINOIS, INDIANA, KENTUCKY, MICHIGAN, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEW JERSEY, NEW YORK, NORTH CAROLINA, OHIO, OREGON, PENNSYL
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0551-2025, Z-0552-2025

Ongoing Class II Medical devices

Recall started
22 May 2024
Reason
Their is a potential that the implantable pulse generator replacement indicator and end of service date may be shorter than indicated in the product labeling potentially resulting in loss of therapy.
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, DC, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, PR, SC, TX, UT, VA, WA, WI, WY and the countries of Algeria, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colom
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2432-2024, Z-2429-2024, Z-2430-2024, Z-2431-2024

Ongoing Class II Medical devices

Recall started
16 May 2024
Reason
The duration between the implantable pulse generator reaching the elective replacement indicator threshold and end of service may be shorter than indicated in product labeling.
Distribution
Worldwide - US Nationwide distribution including in the states of ALABAMA, ALASKA, ARIZONA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, GUAM, HAWAII, IDAHO, ILLINOIS, INDIANA, IOWA, KANSAS, KENTUCKY, LOUISIANA,MAINE, MARYLAND, MASSACHUSETTS, MICHIGA
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2358-2024, Z-2359-2024, Z-2363-2024, Z-2360-2024, Z-2366-2024, Z-2364-2024, Z-2367-2024, Z-2365-2024, Z-2362-2024, Z-2368-2024, Z-2361-2024, Z-2369-2024

Ongoing Class II Medical devices

Recall started
16 May 2024
Reason
Deep brain stimulation system will first turn off after approximately 50 days after the system is activated and subsequently, this same action will recur approximately every 50 days thereafter. This unexpected lost of stimulation may result in loss of therapy.
Distribution
US: Nationwide distribution including in the states of AZ, CA, CO, DC, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NE, NH, NJ, NY, OH OK, OR, PA, SC, SD, TX, UT, WI, WV.
Initiated
Voluntary: Firm initiated
Recall number
Z-2265-2024

Ongoing Class II Medical devices

Recall started
5 February 2024
Reason
Their is a potential that electromagnetic interference may cause leadless pacemaker may result in mode change.
Distribution
US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV. OUS: Pending
Initiated
Voluntary: Firm initiated
Recall number
Z-1695-2024

Ongoing Class II Medical devices

Recall started
16 August 2023
Reason
Due to Bluetooth malfunction on a subset of Implantable Cardioverter Defibrillator (ICD) and Cardia Resynchronization Therapy Defibrillator *CRT-D) devices that were manufactured prior to April 2022 as a result of crystal component issue within the Bluetooth Low Energy (BLE) circuit. This results in the device entering an inductive telemetry only mode with loss of Bluetooth communication. In some instances, thought BLE communication is unavailable, the circuit may remain in a state which draws excessive power affecting battery longevity.
Distribution
U.S.: Nation-wide O.U.S.: Australia, Austria, Bahrain, Belgium, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Korea, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Malaysia, Nepal, Netherlands, New Zealand, Norway, Oman, Polan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2614-2023, Z-2615-2023

Ongoing Class I Medical devices

Recall started
18 July 2023
Reason
Firm has received complaints from patients who are unable to exit MRI (Magnetic Resonance Imaging) mode on their IPGs (Implantable Pulse Generators).
Distribution
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The count
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2507-2023, Z-2505-2023, Z-2510-2023, Z-2511-2023, Z-2506-2023, Z-2509-2023, Z-2508-2023

Terminated Class II Medical devices

Recall started
9 December 2019
Terminated
14 December 2020
Reason
Fast-Cath Trio Hemostasis Introducer devices contained 12F sized dilators and sheaths instead of the expected 14F devices.
Distribution
Worldwide Distributed - US Nationwide in sates of: FL, PA, NY, TX, MI CA, IL, NE, AL, NV, including PR and the countries of: Malaysia, Korea, Paraguay
Initiated
Voluntary: Firm initiated
Recall number
Z-0783-2020

Terminated Class II Medical devices

Recall started
9 December 2019
Terminated
11 December 2020
Reason
Three lots of Fast-Cath Hemostasis Introducer devices contained 8F sized dilators and sheaths instead of the expected 8.5F devices.
Distribution
Worldwide distribution - US Nationwide distribution in the states of MA, VA, NH, FL, CT, UT, OH, WI, NY, IA, MI, MS, PA, and countries of Canada, Czech Republic
Initiated
Voluntary: Firm initiated
Recall number
Z-0789-2020

Terminated Class II Medical devices

Recall started
11 November 2019
Terminated
1 April 2021
Reason
A manufacturing error caused a single lot of 10mm active tip length Cannulas to be labeled as 5mm active tip length cannulas.
Distribution
Worldwide distribution - US Nationwide and country of Bermuda.
Initiated
Voluntary: Firm initiated
Recall number
Z-0720-2020

Terminated Class II Medical devices

Recall started
14 October 2019
Terminated
19 July 2021
Reason
Affected lots were manufactured with the protective release liner in an incorrect orientation. When attempting to remove this disposable release liner, a clear film may be left on the grounding pad which may interfere with patient skin contact and lead to uneven heating.
Distribution
nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0664-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.